Gillmore, Julian D.

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

Gillmore, J. D., Gane, E., Taubel, J., Kao, J., Fontana, M., Maitland, M. L., Seitzer, J., O’Connell, D., Walsh, K. R., Wood, K., et al. (2021) · New England Journal of Medicine

Amyloidosis: Diagnosis, Treatment, OutcomesCRISPR and Genetic Engineering

Cited by 1,801

Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis

Richards, D. B., Cookson, L. M., Barton, S. V., Liefaard, L., Lane, T., Hutt, D. F., Ritter, J. M., Fontana, M., Moon, J. C., Gillmore, J. D., et al. (2018) · Science Translational Medicine

Amyloidosis: Diagnosis, Treatment, OutcomesPrion Diseases and Protein Misfolding

Cited by 136